Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1

Conditions

Pleural Effusion 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Lung Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Cdc25C phosphatase (211-221) × Clear all
NCT00700336 2021-07-20

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

CanBas Co. Ltd.

Phase 1/2 Completed
69 enrolled 9 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00942825 2017-05-24

CBP08-02

CanBas Co. Ltd.

Phase 2 Completed
195 enrolled 8 charts
Thoracic

Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡